Our customer services representatives are available 24 hours a day from Monday to Sunday.
Radiolabeled compounds are molecules that have been tagged with a radioactive isotope, which are the core and cornerstone of radiolabeled science. This incorporation of radioisotopes into compounds allows for the tracking and analysis of biochemical processes, molecular interactions, and the distribution of the compound within a biological system, which is widely used in various scientific fields, including medical research, pharmacology, and environmental studies. In the pharmaceutical field, the use of radiolabeled compounds, particularly those incorporating isotopes like carbon-14 and tritium, has become a cornerstone of drug research. These compounds provide a unique advantage by allowing precise tracking of a drug's journey through the human body and its eventual fate, which are essential for understanding a drug's efficacy and safety profile.
At Alfa Chemistry, we are committed to advancing drug research with cutting-edge radiolabeling and analytical techniques. Our expertise spans from designing and synthesizing radiolabeled compounds to performing in-depth ADME studies of drug. With a focus on delivering high-quality service, we support pharmaceutical companies in optimizing drug candidates, ensuring regulatory compliance, and accelerating time-to-market.
At Alfa Chemistry, our team of experienced synthetic chemists, analytical chemists, and drug metabolism scientists specializes in radiolabeled sciences, offering comprehensive solutions to meet the needs of pharmaceutical research and development. Our services include:
Radiolabeling and Radiosynthesis
Radiolabeling and radiosynthesis form the backbone of radiolabeled sciences. Alfa Chemistry specializes in the custom synthesis of radiolabeled small and large molecular compounds, including carbon-14 and tritium isotopes.
Non-Clinical ADME with Radiolabeled Compounds
Non-clinical ADME studies are essential for understanding the pharmacokinetic properties of drug candidates. Using radiolabeled compounds, Alfa Chemistry provides robust data to guide drug development.
Human Carbon-14 AME Studies Services
Human absorption, metabolism, and excretion (AME) studies using carbon-14 labeled compounds are crucial in late-stage drug development. Alfa Chemistry offers comprehensive AME services to evaluate the safety and efficacy of drug candidates.
Accelerator Mass Spectrometry Analysis Services
Accelerator mass spectrometry (AMS) is a powerful analytical tool that enhances the sensitivity of radiolabeled studies. Alfa Chemistry specializes in applying AMS technology to pharmaceutical research and development.
Alfa Chemistry's radiolabeled sciences service is a trusted partner in drug research and development. By combining advanced radiolabeling techniques, rigorous analytical methods, and regulatory expertise, we help pharmaceutical companies unlock critical insights into their drug candidates. Whether in preclinical studies, clinical trials, or regulatory submissions, our services provide the reliable data necessary for informed decision-making and successful drug development. Please contact us today and let us help you navigate the complexities of drug research with confidence and precision.
Alfa Chemistry is committed to becoming a leading manufacturer and supplier focusing on providing stable isotope compounds and related services.
Privacy Policy | Cookie Policy | Copyright © 2025 Alfa Chemistry. All rights reserved.